Skip to main content
$180.96 $1.63 (0.9%)

04:00 PM EDT on 09/27/22

Repligen Corp (NASDAQ:RGEN)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

Current Price $180.96 Mkt Cap $10.0B
Open $181.86 P/E Ratio 68.45
Prev. Close $180.96 Div. (Yield) $0.00 (0.0%)
Daily Range $176.92 - $182.32 Volume 507,796
52-Wk Range $137.21 - $306.98 Avg. Daily Vol. 536,677

Caps

How do you think NASDAQ:RGEN will perform against the market?

Add Stock to CAPS Watchlist

All Players

642 Outperform
16 Underperform
 

All-Star Players

115 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:RGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

daedalian (< 20)
Submitted September 27, 2021

RGEN is often taken as a normal biotech. It ain't. It's product is in most cases the raw material, reagent, or quality control for the process used by a biotech company to produce product. And in most cases must be resupplied over time. In effect it… More

Skyshadow664 (< 20)
Submitted June 14, 2012

These medical corporations tend to have spurts of large growth with long periods of notable decline. Just as Genetic Technologies as been fluctuating over the past year (a range from ~$2.50 - ~$10.00), this company follows a very similar trend. It… More

Fools bullish on NASDAQ:RGEN are also bullish on:

Fools bearish on NASDAQ:RGEN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about RGEN.

Recs

0
Member Avatar TMFMktmusician (< 20) Submitted: 1/20/2022 4:17:30 PM : Outperform Start Price: $148.87 NASDAQ:RGEN Score: +17.31

https://www.fool.com/investing/2022/01/20/2-healthcare-stocks-that-could-help-set-you-up-for/

Recs

0
Member Avatar TMFSecurity (93.49) Submitted: 11/16/2021 9:08:05 AM : Underperform Start Price: $260.54 NASDAQ:RGEN Score: +8.32

10000000146

Recs

1
Member Avatar daedalian (< 20) Submitted: 9/27/2021 5:08:02 PM : Outperform Start Price: $299.55 NASDAQ:RGEN Score: -22.22

RGEN is often taken as a normal biotech. It ain't. It's product is in most cases the raw material, reagent, or quality control for the process used by a biotech company to produce product. And in most cases must be resupplied over time. In effect it produces the "blades" for the razors the biotechs produce. The notion changes risk/reward calculus. Evidence history of performance.

Leaderboard

Find the members with the highest scoring picks in RGEN.

Score Leader

Stevegoldenfool

Stevegoldenfool (< 20) Score: +5,302.87

The Score Leader is the player with the highest score across all their picks in RGEN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Stevegoldenfool < 20 9/26/2011 Outperform 5Y $3.22 +5,519.88% +217.01% +5,302.87 0 Comment
TXawlman 95.10 10/26/2006 Outperform 5Y $3.37 +5,271.33% +178.54% +5,092.79 1 Comment
toroandbruin 83.60 10/25/2006 Outperform 1Y $3.37 +5,269.73% +178.87% +5,090.87 0 Comment
sincroton < 20 8/25/2006 Outperform 1Y $3.36 +5,285.71% +198.92% +5,086.80 1 Comment
warbucks52 < 20 8/25/2006 Outperform 1Y $3.36 +5,285.71% +199.06% +5,086.66 0 Comment
runic42 < 20 10/2/2006 Outperform 1Y $3.40 +5,222.35% +188.83% +5,033.52 0 Comment
Vanter1 99.51 11/11/2011 Outperform 5Y $3.41 +5,206.74% +186.64% +5,020.10 0 Comment
marky985 < 20 10/27/2008 Outperform 3Y $3.32 +5,350.60% +330.95% +5,019.65 0 Comment
youmustwhipit 69.90 10/27/2008 Outperform NS $3.32 +5,350.60% +330.95% +5,019.65 0 Comment
wonderpiks 97.16 5/6/2010 Outperform 5Y $3.42 +5,191.23% +212.51% +4,978.72 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RGEN.